Center for Scientific Review (CSR)

1. Center for Scientific Review (CSR)

2. National Institutes of Health Office of the Director National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Cancer Institute National Institute of Child Health and Human Development National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute on Drug Abuse National Institute of Environmental Health Sciences National Eye Institute National Institute of General Medical Sciences National Heart, Lung, and Blood Institute National Human Genome Research Institute National Institute of Mental Health National Institute of Neurological Disorders and Stroke National Institute of Nursing Research National Institute of Biomedical Imaging and Bioengineering National Center for Complementary and Alternative Medicine National Library of Medicine National Center on Minority Health and Health Disparities Fogarty International Center National Center for Research Resources Clinical Center Center for Information Technology Center for Scientific Review

3. Center for Scientific Review (CSR) • Focal Point for Initial Review at NIH • Central receipt point for PHS applications • Referral to Institutes and to IRGs and Study Sections • Review of most research and research training applications for scientific merit

4. Applications Submitted to NIH • Approximately 45,000 grant applications are submitted to NIH each year. • CSR is responsible for the review of over half of these applications.

5. CSR Reorganization Initiatives • Examination and re-organization of CSR study sections based on: • integration of review activities of NIMH, NIAAA, and NIDA • alignment of CSR initial review groups and study sections with current trends in science

6. Division of Clinical and Population-Based Studies Elliot Postow, Ph.D. CSR Review Divisions Division of Molecular and Cellular Mechanisms Donald Schneider, Ph.D. Division of Physiological Systems Michael Martin, Ph.D. AIDS and Related Research IRG (ARR) Ranga V. Srinivas, Ph.D. Biochemical Sciences IRG (BCS) Zakir Bengali, Ph.D. Cardiovascular Sciences IRG (CVS)) Jeanne Ketley, Ph.D. Behavioral & Biobehavioral Processes IRG (BBBP) Anita Sostek, Ph.D. Biophysical and Chemical Sciences IRG (BPC) John Bowers, Ph.D. Endocrinology & Reproductive Sciences IRG (ENR) Sooja Kim, Ph.D. Brain Disorders and Clinical Neuroscience IRG (BDCN) Elliot Postow, Ph.D.* Cell Development and Function IRG (CDF) Marcia Steinberg, Ph.D. Integrative, Functional & Cognitive Neuroscience IRG (IFCN) Christine Mellchior, Ph.D. Oncological Sciences IRG (ONC) Syed Quadri, Ph.D. Genetic Sciences IRG (GNS) Camilla Day, Ph.D.* Musculoskeletal & Dental Sciences IRG (MSD) Daniel McDonald, Ph.D. Risk, Prevention and Health Behavior IRG (RPHB) Michael Micklin, Ph.D. Immunological Sciences IRG (IMM) Calbert Laing, Ph.D. Nutritional and Metabolic Sciences IRG (NMS) Sooja Kim, Ph.D. Social Sciences, Nursing, Epidemiology and Methods IRG (SNEM) Robert Weller, Ph.D. Infectious Diseases and Microbiology IRG (IDM) Rona Hirschberg, Ph.D. Pathophysiological Sciences IRG, (PPS) Mustaq Khan, Ph.D. Molecular, Cellular and Developmental Neurosciences IRG (MCDN) Carole Jelsema, Ph.D. Surgery, Radiology, and Bioengineering IRG (SRB) Eileen Bradley, D. Sc. *Acting

7. Number of R01 Applications Reviewed in the Neuroscience Study Sections(10/98 – 10/00 Councils) 46.3% Number of Applications (total = 7015) 16.8% 10.2% 9.3% 8.9% 8.4%

8. Percent of R01 Applications Reviewed in the Neuroscience Study Sections Scoring 15th Percentile or Better(10/98 – 10/00 Councils) n=538 n=189 n=83 n=78 n=58 Percent of Applications Total (3251) (1180) (655) (624) (592)

9. Percent of R01 Applications Reviewed in the Neuroscience Study Sections Scoring 25th Percentile or Better(10/98 – 10/00 Councils) n=894 n=307 n=141 n=134 n=106 Percent of Applications Total (3251) (1180) (655) (624) (592)

10. Number of R01 Applications Reviewed in the Behavioral and Social Sciences Study Sections(10/99 – 10/00 Councils) 25.7% 22.0% 17.7% 14.2% Number of Applications (total = 2294) 11.2% 9.2%

11. Percent of R01 Applications Reviewed in the Behavioral and Social Sciences Study Sections Scoring 15th Percentile or Better(10/99 – 10/00 Councils) n=63 n=100 n=58 n=27 Percent of Applications n=23 Total (590) (406) (326) (257) (211)

12. Percent of R01 Applications Reviewed in the Behavioral and Social Sciences Study Sections Scoring 25th Percentile or Better(10/99 – 10/00 Councils) n=97 n=150 n=93 n=58 n=48 Percent of Applications Total (590) (406) (326) (257) (211)

13. Number of R01 Applications Reviewed in AARR7 and AARR8 Study Sections(10/98 – 10/00 Councils) 38.0% 31.7% Number of Applications (total = 410) 11.2% 10.7% 8.3%

14. Percent of R01 Applications Reviewed in AARR7 and AARR8 Study Sections Scoring 15th Percentile or Better(10/98 – 10/00 Councils) n=7 n=29 n=6 n=15 Percent of Applications Total (156) (130) (46) (34)

15. Percent of R01 Applications Reviewed in AARR7 and AARR8 Study Sections Scoring 25th Percentile or Better(10/98 – 10/00 Councils) n=48 n=10 n=29 Percent of Applications n=7 Total (156) (130) (46) (34)

16. Percent of NIDA R01 Applications Reviewed in “Patient-Oriented” Study Sections Scoring 15th Percentile or Better(10/99 – 10/00 Councils or 10/98 – 10/00 Councils*) n=3 n=3 n=7 n=4 Percent of Applications n=8 Total (77) (13) (32) (17) (45)

17. Percent of NIDA R01 Applications Reviewed in “Patient-Oriented” Study Sections Scoring 25th Percentile or Better(10/99 – 10/00 Councils or 10/98 – 10/00 Councils*) n=5 n=5 n=13 n=6 Percent of Applications n=10 Total (77) (13) (32) (17) (45)

18. Percent of NIDA R01 Applications Scoring 15th Percentile or 25th Percentile or Better in the Neuroscience and Behavioral and Social Science Study Sections (10/98 – 10/00 Councils) Percent of Applications